TITLE

Early initiation of statins following ACS does not improve outcomes

PUB. DATE
August 2006
SOURCE
Journal of Family Practice;Aug2006, Vol. 55 Issue 8, p664
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study on whether early initiation of statins following the onset of acute coronary syndromes (ACS) will reduce the short-term risk of death, recurrent myocardial infarction or stroke. The study was carried out through meta-analysis of randomized controlled trials. The investigators searched electronic databases including the Cochrane Registry, reference lists of identical articles, recently published editorials and topical reviews. The result shows that early initiation of statin therapy within 14 days of the onset of ACS does not reduce the risk of death, recurrent myocardial infarction or stroke up to four months.
ACCESSION #
22379888

 

Related Articles

  • Are High-Risk Hypertensive Patients being Prescribed Concomitant Statin Therapy?: A Retrospective Cohort Study. Chapman, Richard H.; Petrilla, Allison A.; Berman, Lance; Benner, Joshua S.; Tang, Simon S. K. // American Journal of Cardiovascular Drugs;2009, Vol. 9 Issue 5, p299 

    Background: Treatment guidelines for dyslipidemic patients have focused on lipid levels and risk assessments. However, normolipidemic patients who have multiple risk factors for cardiovascular disease may also benefit from HMG-CoA reductase inhibitor (statin) therapy. Objective: We examined the...

  • Smanjenje tereta koronarne bolesti srca na dokazima utemeljenim principima liječenja. Meško, Jasna; Hribar, Veronika; Brus, Sanja; Grošelj, Mateja; Barbič-Žagar, Breda // Cardiologia Croatica;Jan/Feb2014, Vol. 9 Issue 1/2, p76 

    Coronary heart disease (CHD) is the leading cause of death worldwide. Unfortunately, sudden cardiac death is for many individuals the first manifestation of CHD. Prevention ideally begins with primary interventions in persons at increased risk for cardiovascular disease (CVD) but without...

  • Can Statins Alter Coronary Plaque Morphology Assessed by Intravascular Ultrasound? Koza, Yavuzer; Tas, M. Hakan; Simsek, Ziya; Birdal, Oguzhan // Angiology;Jul2014, Vol. 65 Issue 6, p551 

    A letter to editor is presented in response to the article ''Impact of Statin Use before the Onset of Acute Myocardial Infarction on Coronary Plaque Morphology of the Culprit Lesion'' by H. Hikita and others published in a 2013 issue of the periodical.

  • Pravastatin Moderately Decreased Risk for Stroke in Patients with Coronary Artery Disease. H.D., White; R.J., Simes; N.E., Anderson; Frishman, William H. // Annals of Internal Medicine;9/18/2001, Vol. 135 Issue 6, p446 

    Examines the use of a pravastatin therapy for reducing the risk of stroke among patients with coronary artery disease. Association between an increased level of cholesterol and ischemic stroke; Comparison between the occurrence of nonhemorrhagic stroke in placebo and pravastatin recipients;...

  • Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study. Manuel, Douglas G.; Kwong, Kelvin; Tanuseputro, Peter; Lim, Jenny; Mustard, Cameron A.; Anderson, Geoffrey M.; Ardal, Sten; Alter, David A.; Laupacis, Andreas // BMJ: British Medical Journal (International Edition);6/17/2006, Vol. 332 Issue 7555, p1419 

    Objective To examine the potential effectiveness and efficiency of different guidelines for statin treatment to reduce deaths from coronary heart disease in the Canadian population. Design Modelled outcomes of screening and treatment recommendations of six national or international...

  • The Miracle of Niacin. Agatston, Arthur // Prevention;May2009, Vol. 61 Issue 5, p34 

    The article discusses a University of Washington study that shows the benefits of high doses of niacin when taken with statin drugs in lowering the risk factors for heart attack. When taken with statin drugs, niacin raises HDL cholesterol and lowers triglycerides, enlarges the smallest particles...

  • Statins' benefits continue even after treatment.  // Pharmacy Today;Nov2007, Vol. 13 Issue 11, p1 

    The article presents a study which examines the significance of statins, a hypolipidemic agents used to lower cholesterol, even after years a patient stop treatment. Here, the researchers conducted a follow-up survey of approximately 6600 men who took part in the West of Scotland Coronary...

  • Statins Modulate Outcomes in Acute Coronary Syndromes. Sadovsky, Richard // American Family Physician;4/1/2005, Vol. 71 Issue 7, p1416 

    Discusses research being done on the use of statins in treating acute coronary syndromes. Reference to a study by F. A. Spencer et al, published in the June 1, 2004 issue of the journal "Annals of Internal Medicine"; Procedures for the study; Efficacy of the treatment method.

  • A simple test. Comarow, Avery // U.S. News & World Report;5/6/2002, Vol. 132 Issue 15, p55 

    Reports that a blood test for a substance called C-reactive protein, or CRP, is an effective way to identify people at risk of a heart attack or stroke. Comment that sixteen studies have demonstrated the value of CRP testing, according to cardiologist Paul Ridker; Outlook for the use of statin...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics